Abstract
When the outbreak of COVID-19 occurred in 2020, the Chinese government promptly undertook a series of preventive control and medical treatment measures that have effectively reduced the infection and mortality rates of COVID-19. In the process of preventing COVID-19 transmission and treating COVID-19, the Chinese government actively promotes the use of traditional Chinese medicine (TCM), and a series of studies have been carried out to determine the efficacy of TCM for COVID-19. Chinese physicians have accumulated rich experiences and created three Chinese patent medicines (i.e., Lianhua Qingwen Capsule, Jinhua Qinggan Granules, and Xuebijing Injection) and three herbal prescriptions (i.e., Xuanfeibaidu Recipe, Huashi Paidu Recipe, and Qingfei Paidu Decoction), as well as other strategies based on TCM theory to effectively treat COVID-19. Studies have reported that TCM treatment plays a significant role in improving the clinical symptoms, shortening the duration of hospitalization, reducing the overall mortality rate, obtaining favorable treatment outcomes in patients with severe COVID-19, preventing disease progression, improving quality of life and immunity, and reducing the positive rate of viral nucleic acid testing. TCM treatment has a fairly high degree of safety, but the level of evidence needs to be further improved.
Highlights
Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) is caused by the new coronavirus that was first recognized by Chinese scientists in January 2020 [1]
In the process of preventing the transmission of SARS-CoV-2 and treating COVID-19, Chinese physicians have actively conducted studies that have resulted in the identification of three Chinese patent medicines (i.e., Lianhua Qingwen Capsule, Jinhua Qinggan Granules, and Xuebijing (XBJ) Injection) and three herbal prescriptions (i.e., Xuanfeibaidu Recipe, Huashi Paidu Recipe, and Qingfei Paidu Decoction (QFPDD)) based on traditional Chinese medicine (TCM) theory to effectively control the COVID-19 outbreak
Clinical observation of patients with novel coronavirus pneumonia shows that TCM rapidly relieves the symptoms of COVID-19
Summary
Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) is caused by the new coronavirus that was first recognized by Chinese scientists in January 2020 [1]. Studies have found that TCM effectively shortens the duration of hospitalization of patients with COVID, irrespective of the severity of disease. A propensity score-matched analysis found that the overall mortality of patients with severe COVID-19 was significantly lower in the TCM treatment group than the non-TCM treatment group (21.3% [20/94] vs 39.4% [37/94]).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
